What We Offer
Cell immunotherapy for cancer:
Dendritic Cell Therapy
What is cell immunotherapy?
In simple terms, cell immunotherapy (not to be confused with drug-based immunotherapy) is a method of stimulating a powerful effective immune response to allow the body’s immune system to fight disease naturally. Cancer, and other chronic diseases, thrive when the body’s immune system isn’t working properly and is unable to remove defective cells. In many cases, this is because the body doesn’t recognise that these defective cells are dangerous, let’s call them the ‘enemy’. This is because cancer cells are clever and can disguise themselves.
Why use cell immunotherapy as a treatment for cancer?
Cell immunotherapy is a well-established and effective approach to chronic disease management. Although this type of therapy isn’t currently prescribed by mainstream health system pathways, it offers the benefit of being able to be used in tandem with the majority of traditional types of cancer treatments. In addition, it can also reduce the symptoms of harsher cancer treatments such as chemotherapy. Our approach considers the other treatment(s) a patient may be receiving, and our specialists do not prescribe these options in isolation.
Biological Terrain Assessment (BTA)
Your internal ‘biological terrain’ has the ability to either support or inhibit cancer cell growth. A toxic, acidic and oxidative stressed cell and tissue environment is ideal to support cancer cell multiplication, …however the opposite has also shown to be true. It is important to recognise that our ‘biological terrain’ (i.e., the state of our internal health) is critical to managing any chronic disease. It is important to make changes that will help to remove an acidic, toxic and low oxygen environment.
The importance of stimulating the immune system
Dr. de Klyn is a registered physician and member of AVIG and KNMG in the Netherlands. His fields of expertise include surgery, gynaecology and as a General Practitioner. In 1990 he opened a practice for naturopathy and NTTT and also trained in orthopaedic medicine. Dr. de Klyn has been active in medical research since 2006.
- Dr. Bertil de Klyn
How to create a healthier biological terrain that hinders cancer cell growth throughout this challenging time can be confusing and challenging. There is a lot of information available online but it is often time consuming and product promotion based.To help you understand, here is an overview of the accepted biological terrain theory principles:
At Innovita Life we work with experts in the fields of biological terrain, nutrition, supplements and stress management. These specialists are available to you as an optional
choice if you would like further guidance and knowledge to help tackle this component of your health challenge.
A Second Opinion: Medical advice on cancer treatment
Chronic diseases are difficult to control and it can be extremely challenging to improve the patient’s condition and prognosis. Traditional medical systems tend to approach such conditions with their ‘fixed’ knowledge and expertise, but tend to rely on drugs, surgery and radiation in the treatment of cancer.However, the body is designed to heal itself and assistance can be provided in the form of powerful, non-drug-based immunotherapy treatments. In many cases, treatments such as dendritic cell immunotherapy can be applied
alongside traditional medical treatments. This can often provide much better outcomes than tackling the issue with a more ‘fixed’ and narrow approach. Our medical team which includes immunologists, oncologists and radiologists will consider your case in detail to determine if this is a sensible option for you and provide you with a professional opinion on your situation.
“Precision medicine is at the heart of immunotherapy, currently one of the hottest areas of cancer research. Immunotherapy is a new approach that harnesses the power of our immune systems to identify and control diseases such as cancer. Immunotherapy is being studied in just about every type of cancer. The number of cancers successfully treated by immunotherapy stands at 15 and growing and includes skin, lung, kidney and bladder cancers”.